The percentage of CD4 + HLA-DR + CD38 + cells increased significantly between T2 month and the end of the therapy ( p = 0.046), and additionally, we observed an increasing trend between T1 month and T end, between T2 month and T end, and between T3 month and T end.
← all excerpts
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection.
1
—
—